Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial

NJ Palman; RMF Ebisch; DAM Heideman; WJG Melchers; RLM Bekkers; AC Molijn; CLM Meijer; WGV Quint; PJF Snijders; L Massuger; Folkert van Kemenade; J Berkhof

doi:10.1016/s1470-2045(18)30763-0

Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial

NJ Palman, RMF Ebisch, DAM Heideman, WJG Melchers, RLM Bekkers, AC Molijn, CLM Meijer, WGV Quint, PJF Snijders, L Massuger, Folkert van Kemenade, J Berkhof

Pathology

Research output: Contribution to journal › Article › Academic › peer-review

132 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	229-238
Number of pages	10
Journal	Lancet Oncology
Volume	20
Issue number	2
DOIs	https://doi.org/10.1016/s1470-2045(18)30763-0
Publication status	Published - 2019

Research programs

EMC MM-03-24-01

Access to Document

10.1016/s1470-2045(18)30763-0

http://hdl.handle.net/1765/115200

Cite this

Palman, NJ., Ebisch, RMF., Heideman, DAM., Melchers, WJG., Bekkers, RLM., Molijn, AC., Meijer, CLM., Quint, WGV., Snijders, PJF., Massuger, L., van Kemenade, F., & Berkhof, J. (2019). Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial. Lancet Oncology, 20(2), 229-238. https://doi.org/10.1016/s1470-2045(18)30763-0

@article{01ef621da8bd40c2a87e2c32902f4b4d,

title = "Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial",

author = "NJ Palman and RMF Ebisch and DAM Heideman and WJG Melchers and RLM Bekkers and AC Molijn and CLM Meijer and WGV Quint and PJF Snijders and L Massuger and {van Kemenade}, Folkert and J Berkhof",

year = "2019",

doi = "10.1016/s1470-2045(18)30763-0",

language = "Undefined/Unknown",

volume = "20",

pages = "229--238",

journal = "Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "2",

}

Palman, NJ, Ebisch, RMF, Heideman, DAM, Melchers, WJG, Bekkers, RLM, Molijn, AC, Meijer, CLM, Quint, WGV, Snijders, PJF, Massuger, L, van Kemenade, F & Berkhof, J 2019, 'Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial', Lancet Oncology, vol. 20, no. 2, pp. 229-238. https://doi.org/10.1016/s1470-2045(18)30763-0

Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial. / Palman, NJ; Ebisch, RMF; Heideman, DAM et al.
In: Lancet Oncology, Vol. 20, No. 2, 2019, p. 229-238.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial

AU - Palman, NJ

AU - Ebisch, RMF

AU - Heideman, DAM

AU - Melchers, WJG

AU - Bekkers, RLM

AU - Molijn, AC

AU - Meijer, CLM

AU - Quint, WGV

AU - Snijders, PJF

AU - Massuger, L

AU - van Kemenade, Folkert

AU - Berkhof, J

PY - 2019

Y1 - 2019

U2 - 10.1016/s1470-2045(18)30763-0

DO - 10.1016/s1470-2045(18)30763-0

M3 - Article

SN - 1470-2045

VL - 20

SP - 229

EP - 238

JO - Lancet Oncology

JF - Lancet Oncology

IS - 2

ER -

Palman NJ, Ebisch RMF, Heideman DAM, Melchers WJG, Bekkers RLM, Molijn AC et al. Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial. Lancet Oncology. 2019;20(2):229-238. doi: 10.1016/s1470-2045(18)30763-0